Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Price Watch

U.S. Dept HHS: An Important Physicians Organization Suggests More Transparency in Research

Recently, a committed non-profit organization known as Doctors Without Borders/Médecins Sans Frontières (MSF) issued a call for more transparency in clinical research. […]

U.S. Dept HHS An Important Physicians Organization Suggests More Transparency in Research
2 weeks ago
Share

ICER Identifies Most Significant 2019 US Drug-Price Hikes — Even After Rebates — That Were Not Supported by New Clinical Evidence

The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription […]

ICER Identifies Most Significant 2019 US Drug-Price Hikes — Even After Rebates — That Were Not Supported by New Clinical Evidence
1 month ago
Share

Pharma Pricing Scrutinized Again in ICER’s Annual Report of Unsupported Price Increases

Not widely known outside of drug pricing policy and business experts, the Boston-based nonprofit organization known as the Institute for […]

Pharma Pricing Scrutinized Again in ICER’s Annual Report of Unsupported Price Increases
2 months ago
Share

Novo Nordisk Extends COVID-19 Patient Assistance Programs

Danish drug maker Novo Nordisk, a leading producer of diabetes drugs, recently announced it extended its COVID-19 Patient Assistance Program […]

Novo Nordisk Extends COVID-19 Patient Assistance Programs
2 months ago
Share

Lilly Inks Deal Worth up to $1.87 Billion with Feds for its Monoclonal Antibody — $1,250 per dose for up to 680K Doses

On Oct. 9, TrialSite reported Eli Lilly could be on the verge of securing an emergency use authorization (EUA) from the […]

Lilly Inks deal worth up to $12.5 Billion with Feds with its Monoclonal Antibody --$12,500 per dose for up to 680K Doses
4 months ago
Share

Sao Paulo State Seeking ANVISA Greenlight for CoronaVac Registration: Buys 46m at $1.95 per Dose

Sao Paulo state government in Brazil has requested from Brazil’s national health regulator, Anvisa, to register CoronaVac, the vaccine candidate developed […]

Sao Paulo State Seeking ANVISA Greenlight for CoronaVac Registration Buys 46m at $1.95 per Dose
5 months ago
Share

Are Drug Makers Gouging the American Public with Astronomical Prices? Some in Congress Believe So

Congress’ Committee on Oversight and Reform recently detailed a sweeping investigation into “skyrocketing prices of prescription drugs.” The Congressional Committee zeroed […]

Are Drug Makers Gouging the American Public with Astronomical Prices Some in Congress Believe So
5 months ago
Share

Favipiravir Sales Skyrocket in India Targeting Mild COVID-19 Cases

Doctors are prescribing ever more numbers of favipiravir-based drugs for patients with mild COVID-19 as it actually becomes India’s top […]

Favipiravir Sales Skyrocket in India Targeting Mild COVID-19 Cases
5 months ago
Share

Errant Gene Therapeutics (“EGT”) asks European Authorities to Re-examine the Approval Process of Zynteglo, While US Litigation Moves Forward

Picking up on the ongoing “Family Man” saga, in New York Court, EGT claims that Zynteglo, the Bluebird Bio product […]

Errant Gene Therapeutics (“EGT”) asks European Authorities to Re-examine the Approval Process of Zynteglo, While US Litigation Moves Forward
5 months ago
Share

Chief of World’s Busiest Vaccine Manufacturer: The USA & China are ‘Crazy’ for Shunning COVAX Alliance

Adar Poonawalla leads perhaps the busiest vaccine production operation in the world. The billionaire and CEO of Serum Institute of India (SII) […]

Chief of World’s Busiest Vaccine Manufacturer The USA & China are ‘Crazy’ for Shunning COVAX Alliance
5 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.